Evidence for the effect of disease management: is $1 billion a year a good investment?
about
Who gets disease management?Context, mechanisms and outcomes of integrated care for diabetes mellitus type 2: a systematic reviewConvergences and divergences of diabetic patients' and healthcare professionals' opinions of care: a qualitative studyPreventing glycaemic relapse in recently controlled type 2 diabetes patients: a randomised controlled trial.Pay-for-performance in disease management: a systematic review of the literatureStructured chronic primary care and health-related quality of life in chronic heart failure.Application of a theoretical model to evaluate COPD disease managementA web-based nutrition program reduces health care costs in employees with cardiac risk factors: before and after cost analysisThe effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial.A comparison of in-person home care, home care with telephone contact and home care with telemonitoring for disease managementResource use and costs of type 2 diabetes patients receiving managed or protocolized primary care: a controlled clinical trialDisease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectivenessEstimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reductionThe impact of population-based disease management services for selected chronic conditions: the Costs to Australian Private Insurance--Coaching Health (CAPICHe) study protocol.Managing the space between visits: a randomized trial of disease management for diabetes in a community health center.Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider's routine data.Medicare disease management in policy contextEvaluation of Medicare Health Support chronic disease pilot program.15-site randomized trial of coordinated care in Medicare FFSAdvancing current approaches to disease management evaluation: capitalizing on heterogeneity to understand what works and for whom.Economic evaluation of the differential benefits of home visits with telephone calls and telephone calls only in transitional discharge support.A randomized controlled trial of a nurse-led case management programme for hospital-discharged older adults with co-morbidities.Managing chronic pathologies with a stepped mHealth-based approach in clinical psychology and medicine.Health plans' disease management programs: extending across the medical and behavioral health spectrum?A randomized controlled trial evaluating the effectiveness of a web-based, computer-tailored self-management intervention for people with or at risk for COPD.What part of the total care consumed by type 2 diabetes patients is directly related to diabetes? Implications for disease management programs.Substitution of outpatient care with primary care: a feasibility study on the experiences among general practitioners, medical specialists and patients.The Association between Medicare Advantage Market Penetration and Diabetes in the United States.Quality of Disease Management and Risk of Mortality in English Primary Care Practices.The roles of past behavior and health beliefs in predicting medication adherence to a statin regimenSpending differences associated with the Medicare Physician Group Practice Demonstration.The effectiveness of chronic care management for heart failure: meta-regression analyses to explain the heterogeneity in outcomes.Facilitators and Barriers to Care Coordination in Patient-centered Medical Homes (PCMHs) from Coordinators' PerspectivesBridging knowledge to develop an action plan for integrated care for chronic diseases in Greece.A Comparison of Health Plan- and Provider-Delivered Chronic Care Management Models on Patient Clinical Outcomes.What is a hospital? Future roles and prospects for success: the business of medicine: a course for physician leadersIdentifying potentially cost effective chronic care programs for people with COPD.Telephone care management's effectiveness in coordinating care for Medicaid beneficiaries in managed care: a randomized controlled study.The impact of Telephonic Health Coaching on Health Outcomes in a High-risk Population.Comparison of effects between home visits with telephone calls and telephone calls only for transitional discharge support: a randomised controlled trial.
P2860
Q24658155-C3758EB5-CBFF-4D6B-AAF3-432CEA38E04CQ28069287-959CBAD3-48D6-43BC-BF06-F7E94D4314ADQ28391404-303646A3-99AA-4D0D-9608-66D54B8C52F4Q30494321-CE00C644-1FC0-4964-A2C6-678A77D728F9Q31038456-FB34D4E8-B8CD-49E8-B0A6-321B11D433E7Q33471775-D8692B2C-5DF7-4969-8C9F-36830FD9F47FQ33546690-F8566488-5D14-485B-95C2-F10B2DD2B41FQ33575287-72DDE5AB-B50F-461D-90D9-79CFDEDFF9A0Q33739999-9515C7CD-C632-4DAD-B076-CDDAC0CD17A8Q33900177-FC75FA4B-6309-4816-A1AB-A93487A578F6Q33904689-ED028040-9173-41E7-A180-8FFF3D4B6157Q33912718-F4463978-BF76-44D8-91DA-407803B73514Q33931921-1A250543-9896-4DB1-89AA-4DFF9CB8D310Q34156404-825E6EB8-7585-4EF6-A15B-B8D9EC60AC32Q34202068-D57786FF-94D6-4432-B3CD-AA71201BA3EBQ34319956-542A1815-503E-47DD-BB1D-FBE93986348BQ34329000-6CE09994-22E1-4F67-9F94-1CC1DA0B16ECQ34329013-23FA38B2-0745-4106-9A76-4E6C23720CCCQ34329020-E6919197-87F3-4441-9C2D-78ADB89900EAQ34622618-44BD4A88-3731-4E5C-AE17-70E2F3B88A46Q34630997-8F7DB10F-6474-45AA-9BF3-FEC6D3955CDDQ34677493-7183D51B-99B6-4FDB-8EC8-520F45847DC1Q35404700-7C36E775-1A1B-45DE-B918-691EE9C68163Q35509696-0388BEBE-5AC5-4B07-97EF-C0B5026B2E9FQ35743208-5DD2EDA3-71DC-4647-ABF5-EB4FA6E593CEQ35760972-5F95D923-8563-4FA0-89BE-F5972205FC65Q36099363-C64B6285-385F-4AD8-9E49-0E95DE477837Q36133593-415420F5-B4F1-409C-B5DD-86E048C78FF5Q36144413-11F8C8B6-EE4E-43AB-97B0-54145EFF5CADQ36289295-14ED4000-DF34-4BE3-9340-A50E6023C612Q36357610-87C4DCD1-CA68-45D5-981A-4C2AC62209A0Q36442743-433AC346-7583-4992-BFBC-2A1BBE2FCFBBQ36732756-7F8565D2-946B-4352-8FD4-E116898E77BEQ36830779-673FBC7E-D105-4ACE-B3F9-F55792D48D7AQ37004495-CBC28C38-17F4-4EBE-9808-5D7BDCCF3FA6Q37156610-F1685E2C-D198-4789-99E2-CF96A2A41094Q37168313-65134971-3F1D-4959-88F7-3C6B76879A84Q37228421-8505DD40-5DED-44AA-B946-662BD9DD45F6Q37323959-E7226C59-FCF1-45BB-9435-0AF798806202Q37388309-D53936AC-3F53-433C-8CB1-75D18FA63DFD
P2860
Evidence for the effect of disease management: is $1 billion a year a good investment?
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evidence for the effect of disease management: is $1 billion a year a good investment?
@ast
Evidence for the effect of disease management: is $1 billion a year a good investment?
@en
Evidence for the effect of disease management: is $1 billion a year a good investment?
@nl
type
label
Evidence for the effect of disease management: is $1 billion a year a good investment?
@ast
Evidence for the effect of disease management: is $1 billion a year a good investment?
@en
Evidence for the effect of disease management: is $1 billion a year a good investment?
@nl
prefLabel
Evidence for the effect of disease management: is $1 billion a year a good investment?
@ast
Evidence for the effect of disease management: is $1 billion a year a good investment?
@en
Evidence for the effect of disease management: is $1 billion a year a good investment?
@nl
P2093
P1476
Evidence for the effect of disease management: is $1 billion a year a good investment?
@en
P2093
Michael Seid
Soeren Mattke
P304
P577
2007-12-01T00:00:00Z